Ophthalmology

Step into a new era of healing at Infinity Stem Cells, where cutting-edge science meets the body’s innate potential. Our advanced cell regeneration therapies, centered on mesenchymal stem cells (MSCs), harness the transformative power of cellular renewal to address a wide range of conditions, restoring vitality and igniting wellness from within.

|

Ophthalmology

Biologic therapies in ophthalmology aim to preserve, restore, and protect vision by reducing inflammation, stimulating tissue repair, and supporting the health of retinal and ocular structures. These minimally invasive treatments offer an alternative or complement to conventional eye care, particularly for chronic or degenerative conditions.

Common Conditions Treated

Dry Eye Syndrome – Inadequate tear production causing irritation and discomfort
Macular Degeneration – Gradual deterioration of the retina’s central vision area
Diabetic Retinopathy – Blood vessel damage in the retina caused by diabetes
Corneal Ulcers – Open sores on the corneal surface, often from infection or injury
Glaucoma – Optic nerve damage, often linked to elevated intraocular pressure

Treatment Modalities

Exosome Therapy

Delivered via eye drops or micro-injections to repair tissue and calm inflammation

Mesenchymal Stem Cell (MSC) Therapy

MSC-derived biologics that help regenerate retinal cells and support long-term eye health

Platelet-Rich Plasma (PRP)

Concentrated growth factors used topically to accelerate corneal healing

Candidate Selection

Ideal Candidates:

Patients with chronic or degenerative eye conditions seeking regenerative options
Individuals looking to reduce inflammation and slow disease progression

Contraindications:

Active eye infections
Severe uncontrolled systemic autoimmune disorders

Procedure Overview

Preparation

Comprehensive eye exam and baseline visual acuity testing
Maintain a sterile application environment to prevent infection

Administration

Topical Therapy – Biologic-infused eye drops for surface-level conditions
Injection Therapy – Subconjunctival or intravitreal injections for deeper eye structures

Post-Treatment Care

Avoid rubbing or touching the eyes for at least 24 hours
No contact lens use during the first day post-treatment
Attend scheduled follow-ups to track progress and adjust therapy if needed

Supporting Research

Exosome-Based Therapy for Dry Eye – Demonstrates improved tear production and reduced inflammation
MSC-Derived Exosomes for Retinal Repair – Highlights potential benefits in degenerative retinal disease management